Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking

被引:189
作者
Hellmuth, Klaus [1 ]
Grosskopf, Stefanie [2 ]
Lum, Ching Tung [1 ]
Wuertele, Martin [1 ]
Roeder, Nadine [1 ]
von Kries, Jens Peter [2 ]
Rosario, Marta [1 ]
Rademann, Joerg [2 ,3 ]
Birchmeier, Walter [1 ]
机构
[1] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
[2] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany
[3] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany
关键词
chemical biology; growth factor signaling; phosphatase inhibition; virtual drug screening;
D O I
10.1073/pnas.0710468105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The protein tyrosine phosphatase Shp2 is a positive regulator of growth factor signaling. Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene. We performed a high-throughput in silico screen for small-molecular-weight compounds that bind the catalytic site of Shp2. We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1B. PHIPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis. PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin. Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-associated Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines. The PHPS compound class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.
引用
收藏
页码:7275 / 7280
页数:6
相关论文
共 58 条
[1]   Structural and evolutionary relationships among protein tyrosine phosphatase domains [J].
Andersen, JN ;
Mortensen, OH ;
Peters, GH ;
Drake, PG ;
Iversen, LF ;
Olsen, OH ;
Jansen, PG ;
Andersen, HS ;
Tonks, NK ;
Moller, NPH .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (21) :7117-7136
[2]   The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase [J].
Asante-Appiah, E ;
Ball, K ;
Bateman, K ;
Skorey, K ;
Friesen, R ;
Desponts, C ;
Payette, P ;
Bayly, C ;
Zamboni, R ;
Scapin, G ;
Ramachandran, C ;
Kennedy, BP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26036-26043
[3]   A role for the scaffolding adapter GAB2 in breast cancer [J].
Bentires-Alj, M ;
Gil, SG ;
Chan, R ;
Wang, ZGC ;
Wang, YP ;
Imanaka, N ;
Harris, LN ;
Richardson, A ;
Neel, BG ;
Gu, HH .
NATURE MEDICINE, 2006, 12 (01) :114-121
[4]   Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia [J].
Bentires-Alj, M ;
Paez, JG ;
David, FS ;
Keilhack, H ;
Halmos, B ;
Naoki, K ;
Maris, JM ;
Richardson, A ;
Bardelli, A ;
Sugarbaker, DJ ;
Richards, WG ;
Du, JY ;
Girard, L ;
Minna, JD ;
Loh, ML ;
Fisher, DE ;
Velculescu, VE ;
Vogelstein, B ;
Meyerson, M ;
Sellers, WR ;
Neel, BG .
CANCER RESEARCH, 2004, 64 (24) :8816-8820
[5]   The MET receptor tyrosine kinase in invasion and metastasis [J].
Benvenuti, Silvia ;
Comoglio, Paolo M. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (02) :316-325
[6]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[7]   Induction of epithelial tubules by growth factor HGF depends on the STAT pathway [J].
Boccaccio, C ;
Andò, M ;
Tamagnone, L ;
Bardelli, A ;
Michieli, P ;
Battistini, C ;
Comoglio, PM .
NATURE, 1998, 391 (6664) :285-288
[8]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   Opposing actions of CSW and RasGAP modulate the strength of torso RTK signaling in the Drosophila terminal pathway [J].
Cleghon, V ;
Feldmann, P ;
Ghiglione, C ;
Copeland, TD ;
Perrimon, N ;
Hughes, DA ;
Morrison, DK .
MOLECULAR CELL, 1998, 2 (06) :719-727